On the cost-effectiveness of dabigatran. Response

Rev Esp Cardiol (Engl Ed). 2013 Jun;66(6):513. doi: 10.1016/j.rec.2013.02.006. Epub 2013 Apr 23.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticoagulants / therapeutic use*
  • Atrial Fibrillation / complications*
  • Benzimidazoles / therapeutic use*
  • Female
  • Humans
  • Male
  • Stroke / etiology*
  • Stroke / prevention & control*
  • Vitamin K / antagonists & inhibitors*
  • beta-Alanine / analogs & derivatives*

Substances

  • Anticoagulants
  • Benzimidazoles
  • beta-Alanine
  • Vitamin K